Summary

My specialty is molecular biology, and I have been engaged in many pre-clinical studies of pharmaceuticals, in vitro diagnostics and health foods for 10 years. In particular, I have abundant experience in pharmacological studies. I also have 3 years of clinical development experience as a clinical scientist. Using my experience as a system consultant, I have managed various joint research projects in parallel. In addition, I have experience in business planning and business development, so can judge Go / No Go of a project from both science and business perspectives.

Age

37

Work Experience

NITTO BOSEKI CO., LTD.

Researcher / Business Development Representative

April 2012 - March 2014

R&D of in vitro diagnostics (cancer, rheumatoid arthritis)

Planning of new medical business by matching seeds technology inside and outside the company

Deloitte Touche Tohmatsu LLC

Consultant

April 2014 - March 2015

Consultation on business improvement to comply with Social Security and Tax Number System for local governments

SBI Pharma Co., Ltd.

R&D Manager

April 2015 - September 2016

Managed the following business (3 subordinates)

  1. Nonclinical pharmacological studies of 5-aminolevulinic acid (5-ALA)

  2. Quality control and stability test for supplements containing 5-ALA

neopharma Japan Co., Ltd.

Business Development Representative / Scientist / Clinical Scientist

October 2016 - Now

Business Development

  1. Export of 5-ALA-containing supplements and pharmaceutical ingredients to UAE

  2. Transfer of manufacturing technology of 5-ALA-containing supplements to UAE

  3. Health food registration in UAE

Scientist / Clinical Scientist

  1. Conducting nonclinical pharmacological studies mainly for sickle cell disease

  2. Planning and management of more than 10 joint researches (malaria, type1/2 DM, AOSD, FXTAS, ATR-X etc.)

  3. Review of IB, protocol, and CSR

  4. Analysis of clinical results

Education

Graduate School of Science, Nagoya University

Division of Biological Science - MSc

2009 - 2011

Analysis of molecular mechanism of neuronal axon guidance

Development of new gene recombination technology using transposons

Languages

Language

Japanese

Mother Tongue

Language

English

Good

Published papers / Awards

  • Published papers

    The Tol1 element of the medaka fish, a member of the hAT transposable element family, jumps in Caenorhabditis elegans. Kodama K, Takagi S, Koga A. Heredity. 2008 Sep;101(3):222-7.

    5-aminolevulinic acid-induced protoporphyrin IX accumulation does not correlate with ferrochelatase activity in brain tumors. Ken Kodama, Takuya Ishii, Kaori Sakamoto, Yukihiro Fukunaga, Urara Ohta,

  • Awards

    The 17th International C. elegans Meeting (2009, US) Best poster award

    The 82nd annual meeting of the Japanese society of hematology (2020, Japan) Best poster award